BeStock  
Markets › Compare › ADRX vs DMRA

ADRX vs DMRA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ADRX · Adarx Pharmaceuticals$12.79 ▼ 9.68%
DMRA · Damora Therapeutics$23.22 ▼ 4.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

637792106121Sep 25, '26Oct 23, '26Nov 20, '26
  • ADRX -33.9%
  • DMRA +12.4%

Head to head

MetricADRXDMRA
Price$12.79$23.22
Change today▼ 9.68%▼ 4.44%
Market cap$1.42B$1.44B
Return, 3 months–-23.4%
Return, year to date–+0.9%
Return, 1 year–+38.5%
P/E (TTM)–13.6
P/B2.53.9
P/E percentile vs own 5y85th99th
Dividend yield––
Revenue growth (YoY, latest qtr)+258.7%–
Net profit growth (YoY)-42.4%-921.1%
Gross margin––
Operating margin-1,735.0%–
Net margin-1,434.1%–
Return on equity–-156.6%
Analyst target vs. price+173.7%+101.0%
Analyst buy share100%100%
RSI (14)3554
30-day volatility78.8%61.9%
Max drawdown, 1 year-38.0%-46.9%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DMRA is the largest of the group by market value.
  • DMRA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top